Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 16.2B | 14.9B | 11.3B | 11.0B |
Cost of revenue | 10.9B | 10.4B | 6.8B | 6.2B |
Gross profit | 5.3B | 4.5B | 4.6B | 4.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | -48M | -41M |
Other operating expenses | 2.7B | 2.3B | 2.3B | 2.1B |
Operating income | 2.6B | 2.2B | 2.3B | 2.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.1B | 1.3B | 1.1B | 905M |
Other income expense | -670M | 855M | 1.5B | 145M |
Pretax income | 849M | 1.8B | 2.7B | 2.0B |
Tax provision | 231M | 312M | 739M | 386M |
Net income | 618M | 1.4B | 2.0B | 1.6B |
Basic EPS | — | 0.6 | 0.9 | 0.7 |
Diluted EPS | — | 0.6 | 0.9 | 0.7 |
Basic average shares | — | 3.0B | 3.0B | 2.9B |
Diluted average shares | — | 3.0B | 3.0B | 2.9B |
EBITDA | 4.9B | 4.2B | 4.2B | 4.8B |
Net income from continuing op. | 618M | 1.4B | 2.0B | 1.6B |
Minority interests | -23M | -56M | -58M | -53M |
Preferred stock dividends | — | — | — | — |